AHRQ Grant Cancellations Exceed $131M in 28 States

A coalition of healthcare organizations has reported that the Agency for Healthcare Research and Quality (AHRQ) has cancelled grants totaling more than $131 million. These cancellations have impacted 28 states, according to a statement released by the coalition on July 29, 2026. The group, which includes various healthcare providers and research institutions, expressed significant concern over the financial implications and the potential disruption to critical health services and research initiatives funded by these grants. The specific breakdown of which states received the largest cancellations or the exact number of grants affected was not immediately detailed in the coalition's announcement, but the aggregate figure highlights a substantial reduction in federal funding for health research and quality improvement programs.

The AHRQ, a federal agency within the U.S. Department of Health and Human Services, is tasked with producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable. Its grants support a wide range of research, from studies on patient safety and health outcomes to the development of best practices for healthcare delivery. The cancellation of these grants raises questions about the agency's funding priorities and its capacity to support ongoing research projects that are vital for advancing medical knowledge and improving public health. The coalition indicated that the cancellations appear to be part of a broader budgetary reallocation or a strategic shift in the agency's focus, though no official explanation from the AHRQ has been provided regarding these specific cancellations.

This development comes at a time when healthcare systems nationwide are facing numerous challenges, including rising costs, workforce shortages, and the ongoing need to adapt to new public health threats. The loss of AHRQ funding could impede the progress of research aimed at addressing these very issues. For example, grants typically support studies that inform policy decisions, guide clinical practice, and help healthcare providers implement more effective and efficient care models. The coalition is urging the AHRQ and the Department of Health and Human Services to provide greater transparency regarding the decision-making process behind these cancellations and to explore avenues for reinstating or reallocating funds to support essential research. The impact on academic medical centers and research universities, which often rely heavily on federal grants for their operations and scientific endeavors, is expected to be substantial. The coalition plans to continue advocating for the restoration of these funds and for a clearer understanding of the future of AHRQ-supported research.